Showing results (251-260 of 819) with videos related to
Sort By:
Pageof 82
Medicina Clinica|August 5, 2000
[Validity of clinical tests to confirm or exclude the diagnosis of acute myocardial infarction]V F Gil, E Peinado, E Obrador, et al.Medicina Clinica|August 5, 2000
[Validity of clinical tests to confirm or to exclude the diagnosis of acute appendicitis]V F Gil, E Peinado, E Obrador, et al.European Journal of Clinical Investigation|October 1, 1996
Effect of hypercholesterolaemia on platelet growth factorsI García-Bolao, J Merino, A Martínez, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|June 1, 1995
Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissuesS Scala, T Saeki, A Lynch, et al.Atencion Primaria|July 1, 1993
[Medicine at the primary care level (optional undergraduate subject at the University of Alicante): 2 years of experience]V F Gil, F Quirce, M Simón Talero, et al.Endocrine Pathology|July 13, 2002
Genetic Changes in Chromosomes 1p and 17p in Thyroid Cancer ProgressionCelina G. Kleer, Bonita R. Bryant, Thomas J. Giordano, et al.Urology Case Reports|March 5, 2021
Macronodular adrenal hyperplasia masquerading as an upper pole renal massJeunice Owens-Walton, Sandeep Gurram, Maria J Merino, et al.Surgery|September 11, 1992
A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue massesR J Barth, M J Merino, D Solomon, et al.Medicina Clinica|January 22, 1994
[Factors involved in the hypertensive patient non-compliance with treatment]V Gil, C Muñoz, J L Martínez, et al.Anti-Cancer Drugs|February 27, 2023
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cellsHima Patel, Rosalin Mishra, Adam Wier, et al.Pageof 82